Observational Study
Copyright ©The Author(s) 2018.
World J Cardiol. Oct 26, 2018; 10(10): 145-152
Published online Oct 26, 2018. doi: 10.4330/wjc.v10.i10.145
Table 1 Baseline characteristics of our seven patients
Patient APatient BPatient CPatient DPatient EPatient FPatient GAll patients
SexMaleMaleMaleMaleMaleMaleMaleAll male (100%)
Age (yr)8972556785678074 ± 11
Cardiovascular risk factorsHypertensionHypertensionHypertensionHypertensionHypertensionHypertensionHypertensionHypertension (100%)
HyperlipidemiaHyperlipidemiaHyperlipidemiaHyperlipidemiaHyperlipidemiaHyperlipidemiaHyperlipidemiaHyperlipidemia (100%)
Type 2 DMType 2 DMType 2 DMSmokingType 2 DMSmokingType 2 DM (57%)
SmokingSmoking (43%)
PAD historyNoSurgical endatherectomy of the left common femoral artery 2012NoPrior Angioplasty and stent placement in the left popliteal artery 2015NoPrior Angioplasty and stent placement in the left popliteal artery 2016No3/7 (43%)
LV functionModerately reducedNormalNormalNormalSeverely reducedMildly reducedNormalReduced in 3/7 (43%)
Symptoms onsetFor 12 hFor 16 hFor 2 hFor 12 hFor 36 hFor 6 hFor 36 h17 ± 13
CAD history3 vessel CAD3 vessel CADNo3 vessel CAD3 vessel CAD3 vessel CAD3 vessel CAD6/7 (86%)
GABG 2005
Baseline medicationAspirinAspirinAspirinAspirinAspirinAspirinAspirinAspirin (100%)
ß-blockerß-blockerACE inhibitorß-blockerß-blockerß-blockerß-blockerß-blocker (86%)
ACE inhibitorACE inhibitorStatinACE inhibitorACE inhibitorACE inhibitorACE inhibitorACE inhibitor 100%)
StatinStatinStatinStatinStatinStatinStatin (100%)
DiureticsDiureticsDiureticsDiureticsDiuretics (57%)
Other comorbiditiesReduced renal function with estimated GFR of -40 mL/min/1.73 m²Reduced renal function with estimated GFR of -50 mL/min/1.73 m²NoneReduced renal function with estimated GFR of -45 mL/min/1.73 m²Reduced renal function with estimated GFR of -55 mL/min/1.73 m²Reduced renal function with estimated GFR of -50 mL/min/1.73 m²Reduced renal function with estimated GFR of -40 mL/min/1.73 m²Reduced renal function (86%)
Atrial fibrillationAtrial fibrillationAtrial fibrillationAtrial fibrillationAtrial fibrillationAtrial fibrillation (71%)
Heart failureHeart failure NYHA IIIHeart failure NYHA IIHeart failure (43%)
NYHA III
Table 2 Duplex sonography and digital subtraction angiography findings of our patients
Patient APatient BPatient CPatient DPatient EPatient FPatient G
Duplex sonography findingsThrombotic CFA occlusionThrombotic CFA occlusionThrombotic occlusion of the distal SFAThrombotic occlusion of the popliteal arteryThrombotic occlusion of the distal SFAThrombotic occlusion of the distal SFAThrombotic occlusion of the popliteal artery
DSA findingsThrombotic CFA occlusionThrombotic CFA occlusionThrombotic occlusion of the distal SFA and of the popliteal arteryThrombotic occlusion of the popliteal arteryThrombotic occlusion of the distal SFA and of the popliteal arteryThrombotic occlusion of the distal SFA and of the popliteal arteryThrombotic occlusion of the popliteal artery
Treated crural vesselsProximal and mid tibial anterior arteryProximal and mid tibial anterior arteryProximal and mid posterior tibial arteryTibiofibular tract and posterior tibial arteryTibiofibular tract and fibular arteryTibiofibular tractTibiofibular tract and fibular artery
Rotarex catheter6F6F6F6F6F6F6F
Local lysisYesNoNoYesYesYesYes
Second look DSAYesNoNoYesYesYesYes
Table 3 Overview of the diameters of the crural vessels, where 6 French Rotarex®S catheter thrombectomy was performed
Proximal anterior tibial arteryMid anterior tibial artery
Patient A3.2 mm*2.8 mm
Patient B3.4 mm2.7 mm
Proximal posterior tibial arteryMid posterior tibial artery
Patient C3.5 mm3.0 mm
Tibiofibular tractProximal posterior tibial artery
Patient D3.5 mm3.0 mm
Tibiofibular tractProximal fibular artery
Patient E4.0 mm2.5 mm
Tibiofibular tract
Patient F3.5 mm
Tibiofibular tractProximal fibular artery
Patient G4 mm3.5 mm